Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer.
INTRODUCTION: The Institute of Medicine, the American Society of Clinical Oncology, and the European Society of Medical Oncology promote a multidisciplinary approach for the treatment of cancer. Stage III non-small-cell lung cancer (NSCLC) represents a heterogeneous group of diseases necessitating coordination of care among medical, radiation, and surgical oncology. The optimal care of stage III NSCLC underscores the need for a multidisciplinary approach.
METHODS: From tumor registry data, we identified all cases of stage III NSCLC seen at Lehigh Valley Health Network between March 2010 and March 2013. The care received by patients when seen in the thoracic multidisciplinary clinic (MDC) was compared with the care received when not seen in the thoracic MDC.
RESULTS: All patients seen in the MDC, compared to
CONCLUSION: Multidisciplinary care is essential in the treatment of patients with stage III NSCLC. Greater utilization of MDCs for this complex group of patients will result in more efficient coordination of care, pretreatment evaluation, and therapy, which in turn should translate to improve patients' outcomes.
Published In/Presented At
Friedman, E. L., Kruklitis, R. J., Patson, B. J., Sopka, D. M., & Weiss, M. J. (2016). Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer. Journal Of Multidisciplinary Healthcare, 13(9),267-274. doi:10.2147/JMDH.S98345.
Critical Care | Hematology | Medical Sciences | Medical Specialties | Medicine and Health Sciences | Oncology | Pulmonology
Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty